Applied Molecular Transport (AMTI) Earnings Date, Estimates & Call Transcripts → World’s biggest multibillionaire investor is buying THIS by the ton [picture] (From Stansberry Research) (Ad) Free AMTI Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share EarningsStock AnalysisEarningsHeadlinesInsider TradesOwnershipShort InterestSocial MediaStock AnalysisEarningsHeadlinesInsider TradesOwnershipShort InterestSocial Media Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueAMTI Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.AMTI Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Stansberry ResearchWorld’s biggest multibillionaire investor is buying THIS by the ton [picture]Don't Buy Bullion or Mining Stocks. Do THIS Instead As gold continues to break all-time highs, many folks will run out and buy bullion or mining stocks. That's not the best way to ride this gold bull market higher. Note, this showed a 995% gain the last time we shared this same investment idea.Click here to find out what to do. Applied Molecular Transport Analyst EPS EstimatesCurrent Year EPS Consensus Estimate:($0.95) EPSNext Year EPS Consensus Estimate: ($0.76) EPS Applied Molecular Transport Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript11/9/2023Q3 2023($0.50)($0.17)+$0.33($0.17)--8/14/2023Q2 2023$0.77($0.44)($1.21)($0.44)--5/11/2023Q1 2023($0.61)($0.71)($0.10)($0.71)--3/9/2023Q4 2022($0.66)($0.58)+$0.08($0.58)--11/7/2022Q3 2022($0.66)($0.65)+$0.01($0.65)--8/4/2022Q2 2022($0.65)($0.93)($0.28)($0.93)-- Get the Latest News and Ratings for AMTI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Applied Molecular Transport and its competitors with MarketBeat's FREE daily newsletter. 5/9/2022Q1 2022($0.70)($1.10)($0.40)($1.10)--2/24/2022Q4 2021($0.63)($0.78)($0.15)($0.78)-- 11/10/2021Q3 2021($0.62)($0.68)($0.06)($0.68)--8/9/2021Q2 2021($0.60)($0.62)($0.02)($0.62)--5/12/2021Q1 2021($0.75)($0.58)+$0.17($0.58)-- Applied Molecular Transport Earnings - Frequently Asked Questions How much profit does Applied Molecular Transport generate each year? Applied Molecular Transport (NASDAQ:AMTI) has a recorded net income of -$126.32 million. AMTI has generated -$1.90 earnings per share over the last four quarters. What is Applied Molecular Transport's EPS forecast for next year? Applied Molecular Transport's earnings are expected to grow from ($0.95) per share to ($0.76) per share in the next year. More Earnings Resources from MarketBeat Related Companies: Revelation Biosciences Earnings Results ZIVO Bioscience Earnings Results KALA BIO Earnings Results Alaunos Therapeutics Earnings Results Lipocine Earnings Results Freeline Therapeutics Earnings Results Acasti Pharma Earnings Results LianBio Earnings Results Brainstorm Cell Therapeutics Earnings Results Cosmos Health Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future OutlookCSX Co.: The Railroad Powering Ahead with an Earnings Beat What's Driving Tesla Lower Ahead of its Earnings?Blackrock vs. State Street: Earnings in a Volatile MarketWhat to Expect From the Q1 Earnings Reporting SeasonLululemon Stock Implodes Post Earnings, Guidance Muted This page (NASDAQ:AMTI) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsJim Cramer’s “The Biggest Drug Ever”Behind the MarketsYour Money is Not SafeAmerican AlternativeThe AI stock to buy right nowStockEarningsThe only accurate crypto trading system I know …Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Applied Molecular Transport Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
